Carter Robert Ross (CIK 2039341) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-22). Recent activity: Sell TOI (1,604 shares), Sell TOI (1,314 shares), Sell TOI (244 shares), Sell TOI (247 shares), Buy TOI (195 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-22 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Sell | 1,604 | $7,170 |
| 2026-03-18 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Sell | 1,314 | $4,717 |
| 2026-01-06 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Sell | 244 | $895 |
| 2026-01-05 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Sell | 247 | $879 |
| 2025-11-19 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Buy | 195 | $0 |
| 2025-05-22 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Sell | 1,601 | $4,291 |
| 2025-04-02 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Buy | 197,368 | $0 |
| 2025-03-28 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Buy | 9,056 | $9,418 |
| 2025-03-20 | Oncology Institute, Inc. (TOI) | Chief Financial Officer | Sell | 1,150 | $1,024 |
Source: SEC Form 4 filings · as of 2026-05-22